These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 34940832)
21. A structural voyage toward an understanding of the MHC-I-restricted immune response: lessons learned and much to be learned. Gras S; Burrows SR; Turner SJ; Sewell AK; McCluskey J; Rossjohn J Immunol Rev; 2012 Nov; 250(1):61-81. PubMed ID: 23046123 [TBL] [Abstract][Full Text] [Related]
22. Understanding the drivers of MHC restriction of T cell receptors. La Gruta NL; Gras S; Daley SR; Thomas PG; Rossjohn J Nat Rev Immunol; 2018 Jul; 18(7):467-478. PubMed ID: 29636542 [TBL] [Abstract][Full Text] [Related]
23. Strict Assembly Restriction of Peptides from Rabbit Hemorrhagic Disease Virus Presented by Rabbit Major Histocompatibility Complex Class I Molecule RLA-A1. Zhang Q; Liu K; Yue C; Zhang D; Lu D; Xiao W; Liu P; Zhao Y; Gao G; Ding C; Lyu J; Liu WJ J Virol; 2020 Aug; 94(17):. PubMed ID: 32522857 [TBL] [Abstract][Full Text] [Related]
24. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Tynan FE; Reid HH; Kjer-Nielsen L; Miles JJ; Wilce MC; Kostenko L; Borg NA; Williamson NA; Beddoe T; Purcell AW; Burrows SR; McCluskey J; Rossjohn J Nat Immunol; 2007 Mar; 8(3):268-76. PubMed ID: 17259989 [TBL] [Abstract][Full Text] [Related]
25. Perspectives: protein structure. Class-conscious TCR? Wilson IA Science; 1999 Dec; 286(5446):1867-8. PubMed ID: 10610577 [No Abstract] [Full Text] [Related]
26. Do T cells need endogenous peptides for activation? Gascoigne NR Nat Rev Immunol; 2008 Nov; 8(11):895-900. PubMed ID: 18846098 [TBL] [Abstract][Full Text] [Related]
27. Structural and dynamic control of T-cell receptor specificity, cross-reactivity, and binding mechanism. Baker BM; Scott DR; Blevins SJ; Hawse WF Immunol Rev; 2012 Nov; 250(1):10-31. PubMed ID: 23046120 [TBL] [Abstract][Full Text] [Related]
28. MHC class I antigen presentation--recently trimmed and well presented. Flutter B; Gao B Cell Mol Immunol; 2004 Feb; 1(1):22-30. PubMed ID: 16212917 [TBL] [Abstract][Full Text] [Related]
29. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses. Axelsson-Robertson R; Weichold F; Sizemore D; Wulf M; Skeiky YA; Sadoff J; Maeurer MJ Immunology; 2010 Apr; 129(4):496-505. PubMed ID: 20002212 [TBL] [Abstract][Full Text] [Related]
30. Structure and function of major histocompatibility complex class I antigens. Li XC; Raghavan M Curr Opin Organ Transplant; 2010 Aug; 15(4):499-504. PubMed ID: 20613521 [TBL] [Abstract][Full Text] [Related]
31. Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses. Kapp JA; Honjo K; Kapp LM; Goldsmith K; Bucy RP J Immunol; 2007 Aug; 179(4):2105-14. PubMed ID: 17675469 [TBL] [Abstract][Full Text] [Related]
32. Extent of MHC Clustering Regulates Selectivity and Effectiveness of T Cell Responses. Anikeeva N; Fischer NO; Blanchette CD; Sykulev Y J Immunol; 2019 Jan; 202(2):591-597. PubMed ID: 30541879 [TBL] [Abstract][Full Text] [Related]
33. A single autoimmune T cell receptor recognizes more than a million different peptides. Wooldridge L; Ekeruche-Makinde J; van den Berg HA; Skowera A; Miles JJ; Tan MP; Dolton G; Clement M; Llewellyn-Lacey S; Price DA; Peakman M; Sewell AK J Biol Chem; 2012 Jan; 287(2):1168-77. PubMed ID: 22102287 [TBL] [Abstract][Full Text] [Related]
34. The diversity of antigen-specific TCR repertoires reflects the relative complexity of epitopes recognized. Maryanski JL; Casanova JL; Falk K; Gournier H; Jaulin C; Kourilsky P; Lemonnier FA; Lüthy R; Rammensee HG; Rötzschke O; Servis C; López JA Hum Immunol; 1997 May; 54(2):117-28. PubMed ID: 9297530 [TBL] [Abstract][Full Text] [Related]
35. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response. ; ; . PubMed ID: 24690990 [TBL] [Abstract][Full Text] [Related]